Search Results:

 QPReport
can therefore block the approval of generic drugs by submitting overbroad patent descriptions to the FDA, effectively extending their patents to cover non-infringing uses. To combat this problem

 QPReport
two-part test for determining whether a case is "exceptional" under 35 U.S.C. § 285 improperly not patentees) to recoup fees and encouraging patent plaintiffs to bring spurious patent cases to

 QPReport
and establishes a review standard for exceptional case findings in patent cases that is squarely at odds with the highly

 QPReport
prevents an inventor who has assigned a patent from later contesting the patent’s validity a defense of invalidity heard on the merits. LOWER COURT CASE NUMBER: 2019-2054, 2019-2081

 Home - Supreme Court of the United States
arguments, with attorneys for each side of a case given 30 minutes to make a presentation to the meet in a private conference to discuss cases argued earlier that week. The Justices also discuss

 QPReport
a) action for the eminent domain taking of a patent license by the government is a suit for patent "infringement" under the AIA. LOWER COURT CASE NUMBER: 2016-1502

 QPReport
or functional features from a design patent's protected ornamental scope. The court also held that a design-patent holder is entitled to an infringer's entire profits